Journals / Online Türk Sağlık Bilimleri Dergisi / 2026 / Cilt: 7 Sayı: 2

Evaluation of Oxidative Stress Marker and Ischemia Modified Albumin Levels in Patients with Psoriasis Vulgaris

Psoriazis Vulgaris' li Hastalarda Oksidatif Stres Belirteci ve İskemi Modifiye Albümin Düzeylerinin Değerlendirilmesi

Turan Akdağ(NECMETTİN ERBAKAN ÜNİVERSİTESİ)0000-0003-3175-6751
Saadet Kader(Karapınar State Hospital)0000-0003-0646-946X
Gülhan Aksoy Saraç(UFUK UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-8480-4561
Pages
291–296
Publication Date
2022-06-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We aimed to evaluate oxidative stress markers and ischemia modified albumin levels in patients with PS and controls.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: As a systemic inflammatory skin disease, psoriasis vulgaris (PS) is associated with cellular immune mechanisms.
📊
Key Findings & Data:Objective: As a systemic inflammatory skin disease, psoriasis vulgaris (PS) is associated with cellular immune mechanisms.
💡
Conclusion & Impact:We aimed to evaluate oxidative stress markers and ischemia modified albumin levels in patients with PS and controls.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Oksidatif stres · iskemi modifiye albumin · psoriazis vulgaris

Abstract

Objective: As a systemic inflammatory skin disease, psoriasis vulgaris (PS) is associated with cellular immune mechanisms. We aimed to evaluate oxidative stress markers and ischemia modified albumin levels in patients with PS and controls.

Özet

Amaç: Sistemik inflamatuar bir deri hastalığı olan psoriazis vulgaris (PS), hücresel immün mekanizmalarıyla ilişkilidir. Çalışmamızın amacı PS' li hastalarda ve kontrollerde oksidatif stres belirteçleri ve iskemi modifiye albümin düzeylerini değerlendirmektir.

🔖

Cite This Article

Akdağ, T., Kader, S., Saraç, G. A. (2022). Evaluation of Oxidative Stress Marker and Ischemia Modified Albumin Levels in Patients with Psoriasis Vulgaris. Online Türk Sağlık Bilimleri Dergisi, Cilt: 7 Sayı: 2, 291–296. https://doi.org/10.26453/otjhs.1021977

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. Sikar Aktürk A, Ozdoğan HK, Bayramgürler D, Cekmen MB, Bilen N, Kıran R. Nitric oxide and malondialdehyde levels in plasma and tissue of psoriasis patients. J Eur Acad Dermatol Venereol. 2012;26(7):833-837. doi:10.1111/j.1468-3083.2011.04164.x
  2. Karaca S, Guder H. Antioxidant system in dermatology. Turk J Dermatol. 2009;3(2):32-39.
  3. Attwa E, Swelam E. Relationship between smoking-induced oxidative stress and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol. 2011;25(7):782-787. doi:10.1111/j.1468-3083.2010.03860.x
  4. Tekin NS, Ilter N, Sancak B, Ozden MG, Gurer MA. Nitric oxide levels in patients with psoriasis treated with methotrexate. Mediators Inflamm. 2006;2006(3):16043. doi:10.1155/MI/2006/16043
  5. Gisondi P, Bellinato F, Girolomoni G, Albanesi C. Pathogenesis of chronic plaque psoriasis and ıts ıntersection with cardio-metabolic comorbidities. Front Pharmacol. 2020;11:117. doi:10.3389/fphar.2020.00117
  6. Geale K, Henriksson M, Jokinen J, Schmitt-Egenolf M. Association of skin psoriasis and somatic comorbidity with the development of psychiatric illness in a Nationwide SwedishStudy. JAMADermatol. 2020;156(7):795-804.
  7. Kimmel GW, Lebwohl M. Psoriasis: Overview and diagnosis. Evidence-Based Psoriasis. 2018:1-16. doi:10.1007/978-3-319-90107-7
  8. Badri T, Kumar P, Oakley AM. Plaque psoriasis. [Updated 2021 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430879/. Accessed Jan 27, 2022.
  9. Parisi R, Iskandar IYK, Kontopantelis E, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590. doi:10.1136/bmj.m1590
  10. Ayala-Fontánez N, Soler DC, McCormick TS. Current knowledge on psoriasis and autoimmune diseases. Psoriasis (Auckl). 2016;6:7-32. doi:10.2147/PTT.S64950
  11. Ferreira C, Azevedo A, Nogueira M, Torres T. Management of psoriasis in pregnancy - a review of the evidence to date. Drugs Context. 2020;9:2019-11-6. doi:10.7573/dic.2019-11-6
  12. Vičić M, Kaštelan M, Brajac I, Sotošek V, Massari LP. Current concepts of psoriasis ımmunopathogenesis. Int J Mol Sci. 2021;22(21):11574. doi:10.3390/ijms222111574
  13. Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J. 2016;15(1):71. doi:10.1186/s12937-016-0186-5
  14. Pleńkowska J, Gabig-Cimińska M, Mozolewski P. Oxidative stress as an ımportant contributor to the pathogenesis of psoriasis. Int J Mol Sci. 2020;21(17):6206. doi:10.3390/ijms21176206
  15. Lin X, Huang T. Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radic Res. 2016;50(6):585-95. doi:10.3109/10715762.2016.1162301
  16. Asha K, Singal A, Sharma SB, Arora VK, Aggarwal A. Dyslipidaemia & oxidative stress in patients of psoriasis: Emerging cardiovascular risk factors. Indian J Med Res. 2017;146(6):708-713. doi:10.4103/ijmr.IJMR-717-16
  17. Paul S, Sen S, Nath I, Kumar A, Biswas UK. Psoriasis, an inflammatory condition associated with oxidative stress. Asian Journal of Medical Sciences, 2021;12(4):24-30. doi:10.3126/ajms.v12i4.33343
  18. Kaur M, Sharma S, Kukreja S, Kaur J, Bassi R. Study of oxidative stress in patients of psoriasis. Int J Res Dermatol. 2016;2:95-8. doi:10.18203/issn.2455-4529
  19. Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084. doi: 10.1016/j.redox.2018.101084
  20. Qing X, Shi D, Lv X, et al. Prognostic significance of 8-hydroxy-2′-deoxyguanosine in solid tumors: A meta-analysis. BMC Cancer. 2019;19:997. doi:10.1186/s12885-019-6189-9
  21. Kızılyel O, Akdeniz N, Metin MS, Elmas ÖF. Investigation of oxidant and antioxidant levels in patients with psoriasis. Turk J Med Sci. 2019;49(4):1085-1088. doi:10.3906/sag-1807-257
  22. Pektas SD, Pektas G, Oztekin A, et al. Investigation of adropin and IMA levels in psoriasis and their relation to duration and severity of disease. Our Dermatol Online. 2018;9(4):363-368.
  23. Kaur M, Sharma S, Kukreja S, Kaur J, Bassi R. Study of oxidative stress in patients of psoriasis. Int J Res Dermatol. 2016;2(4):95-98.
  24. Mahmouda A, Abo-Elmaged R, Fahmy H, Nada H. Estimation of nitric oxide level in psoriatic patients and its correlation with disease severity. Egypt J Dermatol Venereol. 2013;33(2):71-75.
  25. Mahmouda A, Abo-Elmaged R, Fahmy H, Nada H. Estimation of nitric oxide level in psoriatic patients and its correlation with disease severity. Egypt J Dermatol Venereol. 2013;33(2):71-75.